Answers are grounded in this paper and cite their sources.
Pseudophakic cystoid macular oedema (PCMO) is a common complication following both uncomplicated and complicated cataract surgery, becoming apparent about 6 weeks following surgery.PCMO may be asymptomatic in some cases, but in others is associated with a reduction in visual acuity.The pathogenesis of PCMO is linked to postoperative inflammation and the release of inflammatory mediators.The use of topical steroids and/or nonsteroidal anti-inflammatory drugs can reduce the adverse effects of inflammation and have been used for the prevention and treatment of PCMO.However, the therapeutic effectiveness of these drugs is currently not well understood, partially because PCMO can spontaneously resolve as well as the multiple treatment protocols and the paucity of robust data exist.In this review we compare the various prophylactic options for PCMO and provide commentary on their efficacy.
No takes yet. Share an insight, caveat, or question.
Grzybowski et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: